INSMED Inc — Director's Dealing 2025

Jan 31, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-01-30

Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-30	Common Stock	M	50000	$16.16	Acquired	147083	Direct
2025-01-30	Common Stock	M	41140	$13.67	Acquired	188223	Direct
2025-01-30	Common Stock	S	91140	$80	Disposed	97083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-30	Stock Option (right to buy)	$16.16	M	50000	Disposed	2026-01-07	Common Stock (50000)	Direct
2025-01-30	Stock Option (right to buy)	$13.67	M	41140	Disposed	2027-01-05	Common Stock (41140)	Direct

Footnotes

F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.